Bacterial persisters: molecular mechanisms and therapeutic development
H Niu, J Gu, Y Zhang - Signal transduction and targeted therapy, 2024 - nature.com
Persisters refer to genetically drug susceptible quiescent (non-growing or slow growing)
bacteria that survive in stress environments such as antibiotic exposure, acidic and …
bacteria that survive in stress environments such as antibiotic exposure, acidic and …
Recent progress in Lyme disease and remaining challenges
Lyme disease (also known as Lyme borreliosis) is the most common vector-borne disease in
the United States with an estimated 476,000 cases per year. While historically, the long-term …
the United States with an estimated 476,000 cases per year. While historically, the long-term …
Lyme disease in humans
Lyme disease (Lyme borreliosis) is a tick-borne, zoonosis of adults and children caused by
genospecies of the Borrelia burgdorferi sensu lato complex. The ailment, widespread …
genospecies of the Borrelia burgdorferi sensu lato complex. The ailment, widespread …
[HTML][HTML] Post-treatment Lyme disease as a model for persistent symptoms in Lyme disease
It has long been observed in clinical practice that a subset of patients with Lyme disease
report a constellation of symptoms such as fatigue, cognitive difficulties, and musculoskeletal …
report a constellation of symptoms such as fatigue, cognitive difficulties, and musculoskeletal …
A review of post-treatment Lyme disease syndrome and chronic Lyme disease for the practicing immunologist
KH Wong, ED Shapiro, GK Soffer - Clinical reviews in allergy & …, 2022 - Springer
Lyme disease is an infection caused by Borrelia burgdorferi sensu lato, which is transmitted
to humans through the bite of an infected Ixodes tick. The majority of patients recover without …
to humans through the bite of an infected Ixodes tick. The majority of patients recover without …
Treatment strategies targeting persister cell formation in bacterial pathogens
Persister cells are transiently antibiotic-tolerant and dormant subpopulations that are
produced to escape the effects of antibiotics within biofilms or planktonic cell populations …
produced to escape the effects of antibiotics within biofilms or planktonic cell populations …
Lyme disease and the pursuit of a clinical cure
H Adkison, ME Embers - Frontiers in Medicine, 2023 - frontiersin.org
Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common vector-
borne illness in the United States. Many aspects of the disease are still topics of controversy …
borne illness in the United States. Many aspects of the disease are still topics of controversy …
[BOOK][B] The invisible kingdom: Reimagining chronic illness
M O'Rourke - 2023 - books.google.com
A NEW YORK TIMES BESTSELLER FINALIST FOR THE 2022 NATIONAL BOOK AWARD
FOR NONFICTION Named one of the BEST BOOKS OF 2022 by NPR, The New Yorker …
FOR NONFICTION Named one of the BEST BOOKS OF 2022 by NPR, The New Yorker …
Chronic Lyme disease: An evidence-based definition by the ILADS Working Group
S Shor, C Green, B Szantyr, S Phillips, K Liegner… - Antibiotics, 2019 - mdpi.com
Objective: Chronic Lyme disease has been a poorly defined term and often dismissed as a
fictitious entity. In this paper, the International Lyme and Associated Diseases Society …
fictitious entity. In this paper, the International Lyme and Associated Diseases Society …
Artemisinin as a therapeutic vs. its more complex Artemisia source material
PJ Weathers - Natural Product Reports, 2023 - pubs.rsc.org
Covering: up to 2017–2022 Many small molecule drugs are first discovered in nature,
commonly the result of long ethnopharmacological use by people, and then characterized …
commonly the result of long ethnopharmacological use by people, and then characterized …